ProX MS
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- Undisclosed
Investors
- 3
About ProX MS
, trading as ProX MS, specializes in the development and production of UPLC (ultra-high pressure liquid chromatography) and tandem mass spectrometry systems. It has launched several clinical mass spectrometry devices, including the NGM, C45, C65, and SCT models.
Who invested in ProX MS
3 investors across 1 round
See all investors in ProX MS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 14, 2026
Amount
Undisclosed
Investors
Questions about ProX MS
Who invested in ProX MS?
ProX MS has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ProX MS raised?
ProX MS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ProX MS last raise money?
ProX MS's most recent round on record is a Series A, in Feb 2026.
What does ProX MS do?
, trading as ProX MS, specializes in the development and production of UPLC (ultra-high pressure liquid chromatography) and tandem mass spectrometry systems.
Where is ProX MS headquartered?
ProX MS is headquartered in Ningbo, China.
Which VCs invest in companies like ProX MS?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at ProX MS's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like ProX MS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.